Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?

被引：37

作者：

Pfister, R ^{[1
]}

Schneider, CA ^{[1
]}

机构：

[1] Univ Cologne, Innere Med Klin 3, D-50924 Cologne, Germany

来源：

CLINICA CHIMICA ACTA | 2004年 / 349卷 / 1-2期

关键词：

natriuretic peptides; BNP; NT-pro-BNP; heart failure; left ventricular dysfunction; acute coronary syndrome;

D O I：

10.1016/j.cccn.2004.06.018

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

A growing body of literature describes diagnostic and prognostic value of B-type natriuretic peptides (BNP) in cardiac diseases since it was first described in 1988. As BNP is mainly secreted in the left ventricular (LV) myocardium, BNP was found to reflect LV function much better than any other neurohumoral factor. Thus, BNP is recommended as the first noninvasive blood test for determination of cardiac function by some authors. The introduction of fully automated, rapid bioassays for measurement of BNP and the aminoterminal part of its pro-hormone (NT-pro-BNP) made it possible to use the test even in emergency care settings. Here we review the literature with special focus on assessment of BNP and NT-pro-BNP in the following clinical settings: community screening for LV dysfunction, primary diagnosis of heart failure in general practice and emergency department (ED) and risk stratification in cardiac dysfunction and acute coronary syndromes. In addition, we discuss which applications can be recommended for daily clinical use from the cardiologist's point of view. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：25 / 38

页数：14

共 70 条

[61] Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty [J].

Tateishi, J ;

Masutani, M ;

Ohyanagi, M ;

Iwasaki, T .

CLINICAL CARDIOLOGY, 2000, 23 (10) :776-780

[62] Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations [J].

Troughton, RW ;

Frampton, CM ;

Yandle, TG ;

Espiner, EA ;

Nicholls, MG ;

Richards, AM .

LANCET, 2000, 355 (9210) :1126-1130

[63] Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction - The Framingham Heart study [J].

Vasan, RS ;

Benjamin, EJ ;

Larson, MG ;

Leip, EP ;

Wang, TJ ;

Wilson, PWF ;

Levy, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (10) :1252-1259

[64] Impact of obesity on plasma natriuretic peptide levels [J].

Wang, TJ ;

Larson, MG ;

Levy, D ;

Benjamin, EJ ;

Leip, EP ;

Wilson, PWF ;

Vasan, RS .

CIRCULATION, 2004, 109 (05) :594-600

[65] Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J].

Wang, TJ ;

Larson, MG ;

Levy, D ;

Benjamin, EJ ;

Leip, EP ;

Omland, T ;

Wolf, PA ;

Vasan, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :655-663

[66] A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation [J].

Wieczorek, SJ ;

Wu, AHB ;

Christenson, R ;

Krishnaswamy, P ;

Gottlieb, S ;

Rosano, T ;

Hager, D ;

Gardetto, N ;

Chiu, A ;

Bailly, KR ;

Maisel, A .

AMERICAN HEART JOURNAL, 2002, 144 (05) :834-839

[67] Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care - A randomized, controlled trial [J].

Wright, SP ;

Doughty, RN ;

Pearl, A ;

Gamble, GD ;

Whalley, GA ;

Walsh, HJ ;

Gordon, G ;

Bagg, W ;

Oxenham, H ;

Yandle, T ;

Richards, M ;

Sharpe, N .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (10) :1793-1800

[68] Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure [J].

Wu, AHB ;

Smith, A ;

Wieczorek, S ;

Mather, JF ;

Duncan, B ;

White, CM ;

McGill, C ;

Katten, D ;

Heller, G .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :628-631

[69] Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy [J].

Yamamoto, K ;

Burnett, JC ;

Jougasaki, M ;

Nishimura, RA ;

Bailey, KR ;

Saito, Y ;

Nakao, K ;

Redfield, MM .

HYPERTENSION, 1996, 28 (06) :988-994

[70] Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay [J].

Yeo, KTJ ;

Wu, AHB ;

Apple, FS ;

Kroll, MH ;

Christenson, RH ;

Lewandrowski, KB ;

Sedor, FA ;

Butch, AW .

CLINICA CHIMICA ACTA, 2003, 338 (1-2) :107-115

← 1 2 3 4 5 6 7 →